QUINOXALINE COMPOUNDS

Details for Australian Patent Application No. 2003207266 (hide)

Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors TAKAYAMA, Kazuhisa; MASUDA, Naoyuki; HONDO, Takeshi; HIRABAYASHI, Ryoji; SEKI, Norio; KOGA, Yuji; NAITO, Ryo; OKAMOTO, Yoshinori; KAIZAWA, Hiroyuki; OKUDA, Takao; OKADA, Youhei; TAKEUCHI, Makoto

Pub. Number AU-A-2003207266

PCT Number PCT/JP03/00545

PCT Pub. Number WO2003/062234

Priority 2002-014121 23.01.02 JP

Filing date 22 January 2003

Wipo publication date 2 September 2003

International Classifications

C07D 421/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/5377

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 421/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 2002-014121 23.01.02 JP

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003207266

7 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207267-METHOD OF SCREENING DRUG FOR IMPROVING INSULIN RESISTANCE

2003207265-RNA-DNA LIGATION PRODUCT AND UTILIZATION THEREOF